[Comment] Population-based screening for vascular disease

In The Lancet, Jes Lindholt and Rikke S øgaard1 report the Viborg Vascular (VIVA) trial in which 50 156 Danish men aged 65–74 years were randomly allocated to combined screening for abdominal aortic aneurysm, peripheral arterial disease, and systemic hypertension or to no screening. After a median follow-up of 4·4 years (IQR 3·9– 4·8), screening and subsequent intervention reduced absolute risk of overall mortality by 0·006 (95% CI 0·001–0·011), with a number needed to invite (NNI) to screening to save one life of 169 (89–1811).

Source: LANCET - August 28, 2017 Category: General Medicine Authors: Chadi Ayoub, M Hassan Murad Tags: Comment Source Type: research